At the news
? BEARISHIMPACT 7/10 CLUSTER filed Apr 14, 2026 at 20:00 ET
Bicara Therapeutics executives Claire Mazumdar (CEO) and Ryan Cohlhepp (President/COO) sold a combined $538,203 worth of shares in open-market transactions over a 6-day window. These sales follow derivative exercises and represent material insider selling by two top executives.
- CEO Claire Mazumdar sold 15,000 shares for $354,145.50 on April 20, 2026, following multiple derivative exercises.
- President and COO Ryan Cohlhepp sold 8,000 shares for $184,058.40 on April 15, 2026, after exercising derivatives.
- Total open-market sales in the cluster amount to $538,203, representing approximately 0.034% of the company's $1.6B market cap.
- Both executives exercised in-the-money options prior to selling, with some transactions involving non-cash exercises (code M).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access